References
- Favin FD, Klein-Schwartz W, Oderda GM, Rose SR. In vitro study of lithium carbonate adsorption by activated charcoal. J Toxicol Clin Toxicol 1988; 26(7):443–450.
- Linakis JG, Lacouture PG, Eisenberg MS, Maher TJ, Lewander WJ, Driscoll JL, Woolf AD. Administration of activated charcoal or sodium polystyrene sulfonate (Kayexalate) as gastric decontamination for lithium intoxication: an animal model. Pharmacol Toxicol 1989; 65(5):387–389.
- Scharman EJ. Methods used to decrease lithium absorption or enhance elimination. J Toxicol Clin Toxicol 1997; 35(6):601–608.
- Ismail N. Lithium poisoning. Uptodate version 17.1, topic updated on 5 June 2007. http://www.uptodate.com. Accessed 11 May 2009.
- Roberge RJ, Martin TG, Schneider SM. Use of sodium polystyrene sulfonate in a lithium overdose. Ann Emerg Med 1993; 22(12):1911–1915.
- Ward ME, Musa MN, Bailey L. Clinical pharmacokinetics of lithium. J Clin Pharmacol 1994; 34(4):280–285.
- Gibaldi M, Perrier D. Pharmacokinetics. In: Drugs and the Pharmaceutical Sciences. 2nd ed. Vol. 15. New York: Taylor & Francis Inc; 1992.
- Amdisen A. Serum level monitoring and clinical pharmacokinetics of lithium. Clin Pharmacokinet 1977; 2(2):73–92.
- Bronstein AC, Spyker DA, Cantilena LRJr, Green JL, Rumack BH, Heard SE. Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 25th Annual Report. Clin Toxicol (Phila) 2008 2007; 46(10):927–1057.
- Okusa MD, Crystal LJ. Clinical manifestations and management of acute lithium intoxication. Am J Med 1994; 97(4):383–389.
- Oakley PW, Whyte IM, Carter GL. Lithium toxicity: an iatrogenic problem in susceptible individuals. Aust N Z J Psychiatry 2001; 35(6):833–840.
- Gosselin S. Intoxications par le lithium. Bull Inf Toxicol 2004; 20(1):3–9.
- Gehrke J, Gehrke C. In vitro binding of Li+ ion using a clinical cation exchange resin. Ann Emerg Med 1986; 15(5):651.
- Welch D, Driscoll J, Lewander W, Johnson P. In vitro lithium binding with sodium polysterene sulfonate. Vet Hum Toxicol 1987; 29:472.
- Watling SM, Gehrke JC, Gehrke CW, Zumwalt R, Pribble J. In vitro binding of lithium using the cation exchange resin sodium polystyrene sulfonate. Am J Emerg Med 1995; 13(3):294–296.
- Linakis JG, Hull KM, Lee CM, Maher TJ, Lewander WJ, Lacouture PG. Effect of delayed treatment with sodium polystyrene sulfonate on serum lithium concentrations in mice. Acad Emerg Med 1995; 2(8):681–685.
- Linakis JG, Savitt DL, Wu TY, Lockhart GR, Lacouture PG. Use of sodium polystyrene sulfonate for reduction of plasma lithium concentrations after chronic lithium dosing in mice. J Toxicol Clin Toxicol 1998; 36(4):309–313.
- Linakis JG, Hull KM, Lacouture PG, Lockhart GR, Lewander WJ, Maher TJ. Enhancement of lithium elimination by multiple-dose sodium polystyrene sulfonate. Acad Emerg Med 1997; 4(3):175–178.
- Linakis JG, Eisenberg MS, Lacouture PG, Maher TJ, Lewander WJ, Driscoll JL, Woolf A. Multiple-dose sodium polystyrene sulfonate in lithium intoxication: an animal model. Pharmacol Toxicol 1992; 70(1):38–40.
- Linakis JG, Hull KM, Lacouture PG, Lockhart GR, Lewander WJ, Maher TJ. Sodium polystyrene sulfonate treatment for lithium toxicity: effects on serum potassium concentrations. Acad Emerg Med 1996; 3(4):333–337.
- Linakis JG, Savitt DL, Trainor BJ, Young JE, Lacouture PG. Potassium repletion fails to interfere with reduction of serum lithium by sodium polystyrene sulfonate in mice. Acad Emerg Med 2001; 8(10):956–960.
- Tomaszewski C, Musso C, Pearson JR, Kulig K, Marx JA. Lithium absorption prevented by sodium polystyrene sulfonate in volunteers. Ann Emerg Med 1992; 21(11):1308–1311.
- Belanger DR, Tierney MG, Dickinson G. Effect of sodium polystyrene sulfonate on lithium bioavailability. Ann Emerg Med 1992; 21(11):1312–1315.
- Gehrke JC, Watling SM, Gehrke CW, Zumwalt R. In-vivo binding of lithium using the cation exchange resin sodium polystyrene sulfonate. Am J Emerg Med 1996; 14(1):37–38.
- Goodnick PJ, Fieve RR, Meltzer HL, Dunner DL. Lithium elimination half-life and duration of therapy. Clin Pharmacol Ther 1981; 29(1):47–50.
- Hardy BG, Shulman KI, Mackenzie SE, Kutcher SP, Silverberg JD. Pharmacokinetics of lithium in the elderly. J Clin Psychopharmacol 1987; 7(3):153–158.
- Mendoza SA, Mendoza G. Specialty conference: hemolytic-uremic syndrome. West J Med 1975 123(6):459–466.
- Sodium Polystyrene Sulfonate. DRUGDEX Evaluations, MICROMEDEX healthcare series: Thomson Reuters, Updated 29 April 2009.
- Gerstman BB, Kirkman R, Platt R. Intestinal necrosis associated with postoperative orally administered sodium polystyrene sulfonate in sorbitol. Am J Kidney Dis 1992; 20(2):159–161.
- Rashid A, Hamilton SR. Necrosis of the gastrointestinal tract in uremic patients as a result of sodium polystyrene sulfonate (Kayexalate) in sorbitol: an underrecognized condition. Am J Surg Pathol 1997; 21(1):60–69.